Internship

Intern – Informatics

Confirmed live in the last 24 hours

Cytokinetics

Cytokinetics

501-1,000 employees

Develops drugs for muscle function disorders

Biotechnology
Healthcare

Compensation Overview

$22 - $45Hourly

San Bruno, CA, USA

Paid internship requiring on-site presence at South San Francisco headquarters for approximately 12 weeks.

Category
Bioinformatics
Computational Biology
Biology & Biotech
Required Skills
Python
JavaScript
Git
SQL
Postgres
AWS
REST APIs
Oracle
Data Analysis
HTML/CSS
Requirements
  • Currently enrolled undergraduate student with a computer science major or emphasis in such
  • Strong programming fundamentals and experience with modern development tools
  • Highly focused, organized, detail oriented and motivated team player with good time management skills
  • Experience with software development, data management, and data analysis
  • Excellent written and verbal communication skills
  • Ability to solve problems independently using documentation, online resources, and best practices
  • Interest in biotechnology systems and scientific software solutions
  • Experience with Python, and/or JavaScript/HTML web applications
  • Experience with AWS cloud services (S3, Lambda, EC2)
  • Experience with SQL and database technologies (PostgreSQL or Oracle)
  • Knowledge of version control systems (Git)
  • Understanding of RESTful APIs and web services
Responsibilities
  • Tasked with one or more projects related to systems and data to support biopharmaceutical scientists
  • Apply modern software engineering principles while working on tasks ranging from software system migration, system configuration, data analysis, development of scripts/applications, and potentially machine learning solutions specifically for drug discovery scientists
  • Collaborate with informatics personnel and scientists to achieve project goals

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.

Company Stage

IPO

Total Funding

$58.4M

Headquarters

South San Francisco, California

Founded

1998

Growth & Insights
Headcount

6 month growth

2%

1 year growth

1%

2 year growth

14%
Simplify Jobs

Simplify's Take

What believers are saying

  • Cytokinetics secured $575M funding from Royalty Pharma for drug development and commercialization.
  • Positive Phase III trial results for aficamten in treating obstructive hypertrophic cardiomyopathy.
  • Increased focus on personalized medicine aligns with Cytokinetics' targeted therapies.

What critics are saying

  • Competition from Bristol-Myers Squibb's Camzyos threatens Cytokinetics' market share for aficamten.
  • Reliance on successful clinical trials means negative results could impact financial stability.
  • High drug development costs could strain financial resources if returns are not realized.

What makes Cytokinetics unique

  • Cytokinetics focuses on muscle activators and inhibitors for cardiovascular and neuromuscular diseases.
  • The company targets niche markets like hypertrophic cardiomyopathy and amyotrophic lateral sclerosis.
  • Cytokinetics has a robust pipeline, including drugs like omecamtiv mecarbil and aficamten.

Help us improve and share your feedback! Did you find this helpful?